| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.097 | 0.06 |